Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Rawshani Research AB
AB
Active
Org 5591600530
Havsklinten 10, 436 58
Hovås
General medical practice activities
·
NACE 8621
Est. 2018 · 8 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Rawshani Research AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 1M (-50% vs 2024)
1M
-50%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 788
2 826
1 858
1 502
1 087
Staff expenses
−423
−309
−326
−255
—
EBITDA
656
2 350
1 330
1 081
683
Depreciation & amort.
—
—
—
—
−0
EBIT
656
2 350
1 330
1 081
683
Net financials
−201
−10
−1
−1
—
Profit before tax
289
2 340
1 329
1 080
683
Tax
−103
−486
−279
−223
−141
Net profit
186
1 854
1 050
858
542
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
5 118
4 981
3 131
2 182
1 647
Equity
4 149
3 962
2 312
1 457
1 076
Long-term debt
—
—
—
—
0
Short-term debt
593
809
609
515
361
Total debt
593
809
609
515
361
Financial ratios
5-year trend
EBITDA margin
36,7 %
This company
15,8 %
Market median
This company
Market median
132% above market
2021
2025
Equity ratio
81,1 %
This company
38,2 %
Market median
This company
Market median
112% above market
2021
2025
Return on equity
4,5 %
This company
18,4 %
Market median
This company
Market median
76% below market
2021
2025
Net profit margin
10,4 %
This company
8,1 %
Market median
This company
Market median
28% above market
2021
2025
Asset turnover
0,35×
This company
1,12×
Market median
This company
Market median
69% below market
2021
2025
Debt / equity
0,23×
This company
0,62×
Market median
This company
Market median
63% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Rawshani Research AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
